Literature DB >> 19583732

Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.

William T Lowrance1, R Houston Thompson, David S Yee, Matthew Kaag, S Machele Donat, Paul Russo.   

Abstract

OBJECTIVE: To investigate the association between body mass index (BMI) and histology of renal cell carcinoma (RCC) in a contemporary cohort, as obesity is increasingly prevalent in the USA and might be contributing to the increasing incidence of RCC, but little is known about the relationship of obesity with the different histological subtypes of RCC. PATIENTS AND METHODS: From January 2000 to December 2007 we identified 1640 patients with renal cortical tumours undergoing surgical extirpation at our institution, and who had their BMI recorded. Multivariable logistic regression models were used to test the association of BMI with RCC histology.
RESULTS: The median (interquartile range) BMI was 28 (25-32) kg/m(2) and 38% of patients were classified as obese (BMI >30 kg/m(2)). After adjusting for tumour size, age, gender, American Society of Anesthesiologists score, estimated glomerular filtration rate, hypertension, diabetes mellitus and smoking, the BMI was significantly associated with clear-cell histology; the odds ratios were 1.04 for each unit of BMI (95% confidence interval, CI, 1.02-1.06; P < 0.001) and 1.48 when comparing obese vs non-obese patients (95% CI 1.19-1.84; P < 0.001). In the subgroup of patients with RCC (excluding benign renal cortical tumours), BMI was still an independent predictor of clear-cell histology (odds ratio 1.04, 95% CI 1.02-1.06, P = 0.001).
CONCLUSIONS: These results suggest that BMI is an independent predictor of clear-cell histology in patients with a renal cortical tumour. While the aetiology of this phenomenon requires further study, these findings might have implications in determining a patient's risk of harbouring a clear-cell RCC and in subsequent treatment recommendations.

Entities:  

Mesh:

Year:  2009        PMID: 19583732      PMCID: PMC2818114          DOI: 10.1111/j.1464-410X.2009.08706.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  Targeted therapy for renal cell carcinoma: a new treatment paradigm.

Authors:  Thomas E Hutson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

2.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

3.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

4.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Authors:  R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

5.  Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women.

Authors:  Tone Bjørge; Steinar Tretli; Anders Engeland
Journal:  Am J Epidemiol       Date:  2004-12-15       Impact factor: 4.897

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

Review 7.  The epidemiology of renal cell carcinoma.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

8.  Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Authors:  R Houston Thompson; Susan M Kuntz; Bradley C Leibovich; Haidong Dong; Christine M Lohse; W Scott Webster; Shomik Sengupta; Igor Frank; Alexander S Parker; Horst Zincke; Michael L Blute; Thomas J Sebo; John C Cheville; Eugene D Kwon
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.

Authors:  Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo
Journal:  Ann Surg Oncol       Date:  2004-01       Impact factor: 5.344

10.  Obesity and renal cell cancer--a quantitative review.

Authors:  A Bergström; C C Hsieh; P Lindblad; C M Lu; N R Cook; A Wolk
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

View more
  25 in total

1.  Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.

Authors:  Michele L Cote; Joanne S Colt; Kendra L Schwartz; Sholom Wacholder; Julie J Ruterbusch; Faith Davis; Mark Purdue; Barry I Graubard; Wong-Ho Chow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

Review 2.  Update on cryoablation for treatment of small renal mass: oncologic control, renal function preservation, and rate of complications.

Authors:  Anil Kapoor; Yuding Wang; Brad Dishan; Stephen E Pautler
Journal:  Curr Urol Rep       Date:  2014-04       Impact factor: 3.092

3.  Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.

Authors:  Behfar Ehdaie; Thomas F Chromecki; Richard K Lee; Yair Lotan; Vitaly Margulis; Pierre I Karakiewicz; Giacomo Novara; Jay D Raman; Casey Ng; William T Lowrance; Douglas S Scherr; Shahrokh F Shariat
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

4.  Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours.

Authors:  Christoph A Karlo; Lei Kou; Pier Luigi Di Paolo; Michael W Kattan; Robert J Motzer; Paul Russo; Satish K Tickoo; Oguz Akin; Hedvig Hricak
Journal:  Eur J Cancer       Date:  2016-03-24       Impact factor: 9.162

5.  Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Authors:  Catherine L Callahan; Jonathan N Hofmann; Douglas A Corley; Wei K Zhao; Brian Shuch; Wong-Ho Chow; Mark P Purdue
Journal:  Cancer Epidemiol       Date:  2018-07-18       Impact factor: 2.984

6.  Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?

Authors:  Sandra Steffens; Viktor Grünwald; Kristina I Ringe; Christoph Seidel; Hendrik Eggers; Mark Schrader; Frank Wacker; Markus A Kuczyk; Andres J Schrader
Journal:  Oncologist       Date:  2011-10-21

7.  Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Authors:  Jimmy K Stauffer; Anthony J Scarzello; Jesper B Andersen; Rachel L De Kluyver; Timothy C Back; Jonathan M Weiss; Snorri S Thorgeirsson; Robert H Wiltrout
Journal:  Cancer Res       Date:  2011-02-15       Impact factor: 12.701

8.  The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

Authors:  Tongzhang Zheng; Cairong Zhu; Bryan A Bassig; Simin Liu; Stephen Buka; Xichi Zhang; Ashley Truong; Junhi Oh; John Fulton; Min Dai; Ni Li; Kunchong Shi; Zhengmin Qian; Peter Boyle
Journal:  Int J Epidemiol       Date:  2019-12-01       Impact factor: 7.196

9.  Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery.

Authors:  Bruce R Kava; Ahmed Eldefrawy; Rajinikanth Ayyathurai; Murugesan Manoharan; Mohamed Aziz; Vincent G Bird; Devendar Katkoori; Rajan Ramanathan; Merce Jorda; Gaetano Ciancio; Mark S Soloway; Raymond J Leveillee
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

10.  An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Authors:  Mark P Purdue; Lee E Moore; Maria J Merino; Paolo Boffetta; Joanne S Colt; Kendra L Schwartz; Vladimir Bencko; Faith G Davis; Barry I Graubard; Vladimir Janout; Julie J Ruterbusch; Jennifer Beebe-Dimmer; Michele L Cote; Brian Shuch; Dana Mates; Jonathan N Hofmann; Lenka Foretova; Nathaniel Rothman; Neonilia Szeszenia-Dabrowska; Vsevolod Matveev; Sholom Wacholder; David Zaridze; W Marston Linehan; Paul Brennan; Wong-Ho Chow
Journal:  Int J Cancer       Date:  2013-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.